We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

CD19-Specific T Cells Post AlloSCT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03579888
Recruitment Status : Terminated (Study halted prematurely)
First Posted : July 9, 2018
Last Update Posted : June 2, 2021
Ziopharm Oncology
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 27, 2021
Actual Study Completion Date : May 27, 2021